Page 8 - நோயாளிகள் அப்பால் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நோயாளிகள் அப்பால். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நோயாளிகள் அப்பால் Today - Breaking & Trending Today

Why medical tourism is drawing patients, even in a pandemic

Ceylan Yeginsu, The New York Times
Published: 30 Jan 2021 04:39 PM BdST
Updated: 30 Jan 2021 04:39 PM BdST
A man stands next to a drug store advertisement in Mexicali, a border city in northern Mexico, on Jan 12, 2021. The New York Times
On a cold February morning last year, as she lay curled up in a foetal position on her kitchen floor, Melissa Jackson called her manager at a New Jersey beauty salon to ask for some unpaid time off.
);
}
It was the sixth consecutive week that the 39-year-old beauty technician was unable to work full time because of the debilitating pain in her pelvis caused by endometriosis, a chronic condition triggered by the growth of uterine tissue outside of the uterus. ....

New York , United States , United Kingdom , San Antonio , New Jersey , Costa Rica , Krung Thep Mahanakhon , South Korea , Los Algodones , Martin Wright , Jeff Somerville , Paul Mctaggart , Josef Woodman , Centre For Medical Tourism Research , York Times Company , National Health Service , Delta Air Lines , University Of The Incarnate Word , Tourism Office , Families United , David Vequist , Medical Tourism Research , Incarnate Word , Patients Beyond , National Travel , Medical Tourism ,

TodayIR: Antengene Announces the Acceptance of ATG-010 (Selinexor) NDA by the NMPA for the Treatment of rrMM

(2)
DJ EQS-News: Antengene Announces the Acceptance of ATG-010 (Selinexor) NDA by the NMPA for the Treatment of rrMM EQS-News / 28/01/2021 / 10:33 UTC+8 Antengene Announces the Acceptance of ATG-010 (Selinexor) NDA by the NMPA for the Treatment of rrMM
Shanghai and Hong Kong, PRC, January 28, 2021 Antengene Corporation Limited ( Antengene , SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and /or best-in class therapeutics in hematology and oncology, announced that the National Medical Products Administration (NMPA) accepted its New Drug Application (NDA) for ATG-010 (Selinexor, XPOVIO(R)), a first-in-class oral selective inhibitor of nuclear export (SINE) compound, for the treatment of patients with relapsed/refractory multiple myeloma ( rrMM). This is the fifth NDA for ATG-010 submitted by Antengene, after the four NDAs recently submitted in Australia, South Korea, Singapor ....

New Zealand , Hong Kong , South Korea , Kostenloser Wertpapierhandel , Jay Mei , Asia Pacific , Karyopharm Therapeutics Inc , Marketing Press , Drug Administration , Antengene Corporation Limited , European Medicines Agency , National Medical Products Administration , Connective Tissue Oncology Society , National Comprehensive Cancer Network , Antengene Announces , Corporation Limited , New Drug Application , Karyopharm Therapeutics , Marketing Authorization Application , Medicines Agency , Safety Monitoring Board , Asia Pacific Region , Patients Beyond , Marketing Press Release , Dow Jones Newswires , புதியது ஜீலாந்து ,

Medical tourism is drawing patients, even in a pandemic.

Medical tourism is drawing patients, even in a pandemic.
The U.S. border between Arizona and Nogales, Mexico. Even during the pandemic there has been an increase in travel for medical tourism.Credit.Adriana Zehbrauskas for The New York Times
Jan. 19, 2021
Many people have put off medical procedures, and seen their health deteriorate significantly. The fear of large medical bills has outweighed fear of contagion for some, giving rise to an increased number of patients seeking medical treatment in a foreign country.
“We are seeing a pent-up demand for medical tourism during the pandemic, particularly in the U.S. where a fast-growing number of Americans are traveling across the land border with Mexico for health purposes,” said David G. Vequist IV, the founder of the Center for Medical Tourism Research and a professor at the University of the Incarnate Word in San Antonio. ....

San Antonio , United States , South Korea , Costa Rica , Davidg Vequist , University Of The Incarnate Word , Tourism Research , Families United States , Medical Tourism Research , Incarnate Word , Patients Beyond , Internal Tag To Designate Essential Content , சான் அன்டோனியோ , ஒன்றுபட்டது மாநிலங்களில் , தெற்கு கொரியா , கோஸ்டா ரிக்கா , பல்கலைக்கழகம் ஆஃப் தி அவதாரம் சொல் , சுற்றுலா ஆராய்ச்சி , குடும்பங்கள் ஒன்றுபட்டது மாநிலங்களில் , மருத்துவ சுற்றுலா ஆராய்ச்சி , அவதாரம் சொல் , நோயாளிகள் அப்பால் ,

Antengene to Present at the 39th Annual J.P. Morgan Healthcare Conference

Antengene to Present at the 39th Annual J.P. Morgan Healthcare Conference
SHANGHAI and SAN FRANCISCO, Jan. 11, 2021 /PRNewswire/ Antengene Corporation Limited ( Antengene , SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and oncology, today announced that it will participate in the
39
th Annual J.P. Morgan Healthcare Conference, which is the largest healthcare investment symposium in the industry. Dr. Jay Mei, Founder, Chairman and CEO of Antengene, will present a corporate overview on
Monday, January 11, 2021 at 8:40 a.m. EST (Monday, January 11, 2021 at 9:40 p.m. BJT).
Date:Monday, January 11 ....

Kostenloser Wertpapierhandel , Jay Mei , Asia Pacific , Prnewswire Antengene Corporation Limited , Antengene Corporation Limited , Corporation Limited , Healthcare Conference , Asia Pacific Region , Patients Beyond , Health Care , ஜெய் மெய் , ஆசியா பெஸிஃபிக் , நிறுவனம் வரையறுக்கப்பட்டவை , சுகாதாரம் மாநாடு , ஆசியா பெஸிஃபிக் பகுதி , நோயாளிகள் அப்பால் , ஆரோக்கியம் பராமரிப்பு ,

TodayIR: Antengene Announces its U.S. Partner, -2-

TodayIR: Antengene Announces its U.S. Partner, -2-
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Hong Kong , Kostenloser Wertpapierhandel , Jay Mei , Asia Pacific , Selective Inhibitor Of Nuclear Export , Karyopharm Therapeutics Inc , Marketing Press , Drug Administration , Antengene Corporation Limited , Australian Therapeutic Goods Administration , Approval Program , Health Sciences Authority , European Medicines Agency , Connective Tissue Oncology Society , National Medical Products Administration , National Comprehensive Cancer Network , Antengene Announces , Combination Therapy , Addressable Patient Population , Only Approved Multiple Myeloma Drug Indicated , Once Weekly Bortezomib Combination Regimen , Multiple Myeloma Drug , New Mechanism , Action Approved , Second Line Setting Since ,